Related references
Note: Only part of the references are listed.Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
Eleftheria Chorti et al.
EUROPEAN JOURNAL OF CANCER (2020)
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors
Jennifer Choi et al.
SUPPORTIVE CARE IN CANCER (2020)
Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy
Zoe Apalla et al.
SUPPORTIVE CARE IN CANCER (2020)
FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis
Yang Lu
CLINICAL NUCLEAR MEDICINE (2019)
Sarcoid-like reaction and vitiligo occurring after nivolumab therapy in a patient with metastatic melanoma
Kensuke Fukuchi et al.
JOURNAL OF DERMATOLOGY (2019)
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma
Erika F. Rodriguez et al.
HUMAN PATHOLOGY (2019)
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
Pooja H. Rambhia et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary
Rima I. Tulbah et al.
CLINICAL NUCLEAR MEDICINE (2019)
A case of erythema nodosum-like panniculitis induced by nivolumab in a patient with oesophageal cancer
Myoung Eun Choi et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)
Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings
J. Cervantes et al.
ACTAS DERMO-SIFILIOGRAFICAS (2019)
Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma
Randi Woodbeck et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2018)
Ipilimumab-Induced Sarcoidosis and Thyroiditis
Sravanthi Nandavaram et al.
AMERICAN JOURNAL OF THERAPEUTICS (2018)
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
Alexander T. Faje et al.
CANCER (2018)
Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction
Alexandre Laroche et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
Pembrolizumab-induced sarcoidal infusion site reaction
Emily Y. Chu
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors
Ioannis Gkiozos et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases
Henrik Jespersen et al.
LANCET ONCOLOGY (2018)
Sarcoid-like reactions in patients receiving modern melanoma treatment
Florentia Dimitriou et al.
MELANOMA RESEARCH (2018)
Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission
N. Yatim et al.
REVUE DE MEDECINE INTERNE (2018)
Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor Therapy
Leo L. Wang et al.
JAMA DERMATOLOGY (2018)
Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event
Mizuki Nishino et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Pembrolizumab-Related Sarcoid-Like Reaction Presenting as Reactivation of Quiescent Scars
Mary Clare McKenna et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy
Irena Tan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient
Susumu Noguchi et al.
CASE REPORTS IN ONCOLOGY (2018)
Neurosarcoidosis following Immune Checkpoint Inhibition
Anastasie M. Dunn-Pirio et al.
CASE REPORTS IN ONCOLOGY (2018)
Pulmonary sarcoid-like granulomatosis induced by nivolumab
H. Montaudie et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors
Belal Firwana et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2017)
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
Sebastien Le Burel et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis
Anna J. Lomax et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapyReport of 2 patients
Michael T. Tetzlaff et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
Swathi B. Reddy et al.
JOURNAL OF IMMUNOTHERAPY (2017)
EBUS-TBNA Can Distinguish Sarcoid-Like Side Effect of Nivolumab Treatment from Tumor Progression in Non-Small Cell Lung Cancer
Segolene Lainez et al.
RESPIRATION (2017)
Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum
Sara Burillo-Martinez et al.
JAMA DERMATOLOGY (2017)
Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
Ghina Fakhri et al.
CASE REPORTS IN ONCOLOGY (2017)
Ipilimumab-Induced Granulomatous Disease Occurring Simultaneously With Disease Progression in a Patient With Metastatic Melanoma
Anis Toumeh et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab
S. Cousin et al.
ANNALS OF ONCOLOGY (2016)
Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma
Francois-Xavier Danlos et al.
CHEST (2016)
Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy
L. Martinez Leborans et al.
DERMATOLOGIC THERAPY (2016)
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature
Joshua E. Reuss et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
New-Onset Mediastinal and Central Nervous System Sarcoidosis in a Patient with Metastatic Melanoma Undergoing CTLA4 Monoclonal Antibody Treatment
Kevin P. Murphy et al.
Oncology Research and Treatment (2016)
Sarcoidosis complicating anti-cytotoxic T-Iymphocyte-associated antigen-4 monoclonal antibody biotherapy
Claire Tissot et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab
Ross B. Reule et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment
Kentaro Inoue et al.
SPRINGERPLUS (2013)
Pulmonary Sarcoid-Like Granulomatosis Induced by Ipilimumab
Gregoire Berthod et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Ipilimumab-Induced Sarcoidosis in a Patient With Metastatic Melanoma Undergoing Complete Remission
Wouter V. Vogel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Anti-CTLA4 Monoclonal Antibody Induced Sarcoidosis in a Metastatic Melanoma Patient
A. Eckert et al.
DERMATOLOGY (2009)
Share Paper
